XML 259 R96.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and contingencies (Narrative) (Details)
 1 Months Ended 12 Months Ended
Jul. 15, 2021
USD ($)
Jul. 08, 2021
USD ($)
May 06, 2021
GBP (£)
Mar. 09, 2021
GBP (£)
Jul. 31, 2021
GBP (£)
Jul. 31, 2021
USD ($)
Oct. 26, 2020
CAD ($)
Jul. 29, 2020
GBP (£)
Dec. 31, 2021
CAD ($)
Dec. 31, 2021
USD ($)
Disclosure of contingent liabilities [line items]                    
Claimant value | £       £ 400,000            
Cost order | £     £ 10,287              
Claim settlement amount         £ 165,000 $ 228,373 $ 5,500,000      
Provision for employee related liability | £               £ 59,748    
Parkway Clinical Laboratories                    
Disclosure of contingent liabilities [line items]                    
Failed to pay for services   $ 1,412,951                
Raza Bokhari                    
Disclosure of contingent liabilities [line items]                    
Severance and damages amount $ 30,200,000                  
Punitive damages $ 500,000                  
Epitech License Agreement                    
Disclosure of contingent liabilities [line items]                    
Non refundable sum due and payable upon first notification of FDA                   $ 700,000
Non refundable sum due and payable thirty days upon first notification of FDA                   500,000
Non refundable sum payable within required business days of first notification FDA                   $ 1,000,000
Percentage of lump sum payment received to pay for non prescription drug rights                   25.00%
Percentage of one off lump sum payment to pay for prescription drug rights                   5.00%
Percentage of net sales of Licensed Product as first payment condition                 7.00%  
Percentage of net receipts from commercial partners as second payment condition                 25.00%  
Percentage of net sales or net receipts of licensed products as third payment condition                 5.00%  
Innovet License Agreement                    
Disclosure of contingent liabilities [line items]                    
Non refundable sum due and payable upon first notification of FDA                   $ 250,000
Non refundable sum payable within required business days of first notification FDA                   $ 750,000
Percentage of lump sum payment received to pay for non prescription drug rights                   14.00%
Percentage of one off lump sum payment to pay for prescription drug rights                   5.00%
License agreement | Lucid-MS and Lucid-Psych                    
Disclosure of contingent liabilities [line items]                    
License maintenance fee                 $ 100,000  
License agreement | Lucid-MS and Lucid-Psych | Minimum                    
Disclosure of contingent liabilities [line items]                    
Milestones payments                 0  
License agreement | Lucid-MS and Lucid-Psych | Maximum                    
Disclosure of contingent liabilities [line items]                    
License maintenance fee                 $ 12,500,000